hydroxyurea has been researched along with Diabetes Mellitus, Type 1 in 1 studies
Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Conti, M | 1 |
| Meneghini, E | 1 |
| Fumagalli, G | 1 |
| Guidoni, F | 1 |
| Bertuzzi, F | 1 |
| Pintaudi, B | 1 |
1 other study available for hydroxyurea and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Severe hypoglycemia caused by hydroxyurea interference on continuous glucose sensor integrated with advanced hybrid closed-loop system: a case report.
Topics: Blood Glucose; Blood Glucose Self-Monitoring; Diabetes Mellitus, Type 1; Glucose; Humans; Hydroxyure | 2023 |